• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Assertio Holdings, Inc. - Common Stock (NQ:ASRT)

0.8421 +0.0071 (+0.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 325,501
Open 0.7920
Bid (Size) 0.8472 (4)
Ask (Size) 0.8799 (5)
Prev. Close 0.8350
Today's Range 0.7850 - 0.8679
52wk Range 0.5137 - 1.160
Shares Outstanding 44,494,051
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are moving after the closing bell on Friday?
September 19, 2025
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
DEADLINE NEXT WEEK: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Contact the Firm Before September 24, 2025
September 18, 2025
From Berger Montague
Via GlobeNewswire

Performance

YTD
-0.9%
-0.9%
1 Month
+3.5%
+3.5%
3 Month
+22.8%
+22.8%
6 Month
+35.4%
+35.4%
1 Year
-24.8%
-24.8%

More News

Read More
SHAREHOLDER ALERT: Berger Montague Reminds Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors of Class Action Lawsuit Deadline
August 18, 2025
From Berger Montague
Via GlobeNewswire
Assertio Holdings Earnings Preview
August 08, 2025
Via Benzinga
Notice of Pendency of Action on Behalf of Purchasers of Spectrum Pharmaceuticals, Inc. (SPPI) Common Stock and the Reopening of the Lead Plaintiff Process
August 14, 2025
Via NewMediaWire
Topics Regulatory Compliance
Notice of Pendency of Action on Behalf of Purchasers of Spectrum Pharmaceuticals, Inc. (SPPI) Common Stock and the Reopening of the Lead Plaintiff Process
August 14, 2025
Via TheNewswire.com
Topics Regulatory Compliance
ATTENTION NASDAQ: SPPI INVESTORS: Contact Berger Montague About a Spectrum Pharmaceuticals Class Action Lawsuit
August 07, 2025
From Berger Montague
Via GlobeNewswire
Earnings Scheduled For May 12, 2025
May 12, 2025
Via Benzinga
A Look at Assertio Holdings's Upcoming Earnings Report
May 09, 2025
Via Benzinga
A Look at Assertio Holdings's Upcoming Earnings Report
November 08, 2024
Via Benzinga
Recap: Assertio Holdings Q4 Earnings
March 11, 2024
Via Benzinga
Earnings Scheduled For August 11, 2025
August 11, 2025
Via Benzinga
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
March 21, 2025
Via ACCESS Newswire
Earnings Scheduled For March 12, 2025
March 12, 2025
Via Benzinga
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
February 12, 2025
From DiCello Levitt LLP
Via GlobeNewswire
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer
December 06, 2024
From Beam Therapeutics
Via GlobeNewswire
Earnings Scheduled For November 11, 2024
November 11, 2024
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via Benzinga
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 03, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
June 13, 2024
Via Benzinga
Sidoti Events, LLC's Virtual June Small-Cap Conference
June 11, 2024
Via ACCESSWIRE
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
June 07, 2024
Via Benzinga
ASRT Stock Earnings: Assertio Holdings Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
Via InvestorPlace
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 27, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via Benzinga

Frequently Asked Questions

Is Assertio Holdings, Inc. - Common Stock publicly traded?
Yes, Assertio Holdings, Inc. - Common Stock is publicly traded.
What exchange does Assertio Holdings, Inc. - Common Stock trade on?
Assertio Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Assertio Holdings, Inc. - Common Stock?
The ticker symbol for Assertio Holdings, Inc. - Common Stock is ASRT on the Nasdaq Stock Market
What is the current price of Assertio Holdings, Inc. - Common Stock?
The current price of Assertio Holdings, Inc. - Common Stock is 0.8421
When was Assertio Holdings, Inc. - Common Stock last traded?
The last trade of Assertio Holdings, Inc. - Common Stock was at 10/13/25 04:00 PM ET
What is the market capitalization of Assertio Holdings, Inc. - Common Stock?
The market capitalization of Assertio Holdings, Inc. - Common Stock is 37.47M
How many shares of Assertio Holdings, Inc. - Common Stock are outstanding?
Assertio Holdings, Inc. - Common Stock has 37M shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  244.64
+7.15 (3.01%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap